Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-16, Stock:LLY, The news for the past five days is as follows:
2021-09-09: NEWS1: Here's Why ProQR Stock Surged on Thursday.NEWS2: Biogen Stock Dives As CEO Admits 'Slower Than We Anticipated' Alzheimer's Drug Launch.NEWS3: Lilly Prices First Sustainability Bond to Advance Global ESG Strategy.NEWS4: FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction.NEWS5: Eli Lilly Inks Another RNA Collab, This Time With ProQR.
2021-09-10: NEWS1: Lilly's (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF.NEWS2: Pharma Stock Roundup: SNY to Buy Kadmon, New Approvals for AZN & MRK's Drugs.
2021-09-13: NEWS1: Top Research Reports for Eli Lilly, Exxon Mobil & Lowe's.NEWS2: Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conference.NEWS3: Lilly to Present New Data from Oncology Portfolio at ESMO Congress.
2021-09-14: nan
2021-09-15: NEWS1: Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval From MHLW.NEWS2: After Regeneron, US Government Orders Additional COVID-19 Therapy From Eli Lilly.NEWS3: The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs.NEWS4: UPDATE 1-U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy.NEWS5: Eli Lilly to supply the U.S. government with doses of COVID-19 treatment etesevimab for $330 million.NEWS6: Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19.

Answer: Decrease